IDHC
NEUTRALIntegrated Diagnostics Holdings Publishes 2024 Annual Report and Announces AGM
The healthcare diagnostics company has published its 2024 annual report and announced the date for its upcoming annual general meeting.
Integrated Diagnostics Holdings
0.3553USD
1.51%
Market Cap
211.27M
Volume
2.19k
1% of avg
P/E Ratio
0.20
EPS (TTM)
1.77
Beta
0.26
Day Range
0.3400p - 0.3580p
52 Week Range
0.2750p0.3553p0.5400p
0.3553p
Upcoming Events
IDHC
GOODIDH Reports Strong 39% Revenue Growth and 115% Profit Surge in 2024 Results
The diagnostics services provider reported a 39% revenue surge and 115% profit increase, driven by higher test volumes and improved margins. Despite strong performance, the company faces challenges in certain markets and economic uncertainties.
IDHC
NEUTRALIntegrated Diagnostics Holdings Provides General Update
The healthcare company provides a general update on its operations in the Middle East and Africa.
IDHC
GOODIDH Expands Footprint in Saudi Arabia with Increased Stake in Biolab KSA
The healthcare provider is expanding its presence in Saudi Arabia by increasing its stake in a local subsidiary, signaling confidence in the market's growth potential.
IDHC
GOODIntegrated Diagnostics Holdings Reports Robust 9M 2024 Results
The diagnostics provider reported robust 9M 2024 results, with double-digit growth in revenue and profitability. Expansion into Saudi Arabia progressing well, though challenges persist in Nigeria and Sudan.
IDHC
NEUTRALIntegrated Diagnostics Holdings Announces Upcoming Results Release
Diagnostics company announces upcoming results release, generating anticipation among investors.
IDHC
NEUTRALIntegrated Diagnostics Delays Treasury Shares Removal
Healthcare diagnostics company provides update on administrative process
IDHC
NEUTRALIntegrated Diagnostics Holdings Completes EGX Delisting
The diagnostics company has completed the voluntary delisting of its shares from the Egyptian Exchange, with its shares now solely listed on the London Stock Exchange.
IDHC
VERY GOODIDH Reports Strong 33% Revenue Growth in Half-Year Results, Expands into Saudi Arabia
The diagnostics services provider reported impressive 33% revenue growth, 45% EBITDA increase, and 127% net profit surge in H1 2024. Successfully expanded into Saudi Arabia, demonstrating strong growth trajectory despite regional challenges.
IDHC
NEUTRALIntegrated Diagnostics Holdings Announces Upcoming Results Release
The diagnostics company will publish its financial results for the first half of 2024 on 28 August. An analyst and investor call is scheduled for 2 September.